55 results
8-K
EX-99.1
EQ
Equillium Inc
8 Mar 24
Departure of Directors or Certain Officers
4:01pm
in which the Company or the Affiliate is domiciled or incorporated, as the case may be.
(e) Change in Time Commitment. In the event a Participant’s … regular level of time commitment in the performance of such Participant’s services for the Company and any Affiliates is reduced (for example, and without
PRE 14A
01i3d3mzi7knk734lk
31 Mar 23
Preliminary proxy
4:02pm
425
a7gx8 r9ievp0
6 Dec 22
Business combination disclosure
7:02am
8-K
EX-99.1
akbec fvos3k8s9
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am
424B3
0z595 xwt
10 Nov 22
Prospectus supplement
4:13pm
S-4/A
fyi239tjhquanoql 06
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
xj9r5f5lfj1nv6pm2 wv
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm
425
v5ssl
6 Sep 22
Business combination disclosure
4:33pm
8-K
EX-2.1
5svm ers0lu
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K/A
EX-99.1
vp5c pt0xle
2 May 22
Financial Statements and Exhibits
1:19pm
8-K/A
EX-99.2
kljw 1e7mwaw
2 May 22
Financial Statements and Exhibits
1:19pm